Participating Investors
Please check back for an updated list of participating investors.
203 Investment Partners
5AM Ventures
Abbott Biotech Ventures
Abingworth
Aisling Capital
Alafi Capital Company
Alta Partners
Amgen, Inc.
Apposite Capital
Asset Management Company
Astellas Venture Management
ATEL Ventures
Bailard, Inc.
Barclays Capital
Bay City Capital
BDC Venture Capital
Biogen Idec
Biotechnology Value Fund, LP
Black River Asset Management
Boenning & Scattergood
BSI Healthcapital
Burrill & Company
BWS Financial Inc.
Canaan Partners
Canaccord Adams
Capital Midwest
Care Capital
Cato BioVentures
Celtic Pharma Holdings Advisors LLP
Celtic Pharma Management LP
Celtic Pharma West Coast
CHL Medical Partners
CIDC Consultants, Inc.
CMEA Capital
Compass Tech Partners
Cummings Bay Capital
Cumuls Capital Management
DAFNA Capital Management, LLC
Deerfield Management
Delphi Ventures
Deutsche Bank AG
Domain Associates, LLC
Dovedale Investments
Ernst & Young LLP
Essex Investment Management Company
Evolvence India Life Science Fund
Favus Institutional Research LLC
Franklin Advisors
Franklin Templeton Investments
Frazier Healthcare Ventures
Fusion Capital Partners
GE Capital
Genentech
Genesys Capital
Goldman Sachs
Griffin Securities, Inc.
Growthworks Capital Ltd
H.I.G. BioVentures
Hatteras Venture Partners
HBM Partners
HealthCare 250 LP
Helix Ventures
Hercules Technology Growth Capital
High Country Venture
Innovation Ventures
International Venture Fund
Intersouth Partners
InterWest Partners
Itochu
ItX International
JAFCO Life Science Investment
Janus Capital
JAPAN ASIA INVESTMENT Co,.Ltd.
Jina Ventures Inc.
JMP Securities
Johnson & Johnson Development Corporation
Kaiser Permanente Ventures
Kearny Venture Partners
Kingsbridge Capital
Ladenburg, Thalmann, & Co.
Latterell Venture Partners
Laufer Advisors
Lilly Ventures
Lumira Capital
Maxwell Biotech
MDB Capital Group
MedImmune Ventures
Mesa Verde Venture Partners
Mitsubishi International Corp
Mitsui & Co. Ventures Partners, Inc.
Monness, Crespi, Hardt & Co.
Morgan Joseph
MP Healthcare Venture Management
MPM Capital
NDI Capital Inc.
New Enterprise Associates
New Leaf Venture Partners
Nomura Phase4 Ventures
Nordic Biotech Advisors
Novartis Venture Fund
Novo A/S
Novo Nordisk A/S
Numoda Capital Innovations
OCIF Asset Management Co Ltd
Omega Funds
OrbiMed Advisors
Outer Islands Capital
Oxford Finance Corporation
P. Schoenfeld Asset Management (PSAM)
Pacific Horizon Ventures
Pacific Paragon Group of Companies
Pac-Link Bioventures
Palo Alto Investors
Panorama Capital
Paperboy Ventures LLC
Partner Fund Management
Paul Capital
Physic Ventures
PioneerPath Capital
Polaris Venture Partners
Prospect Venture Partners
Radius Ventures
Ram Partners, LP
RBC Capital Markets
RCM Capital Management, LLC
Red Abbey Venture Partners
Riverbank Capital
Rodman & Renshaw, LLC
RRC Capital
RS Investments
Sears Capital Management, Inc
Sherbrook Capital Management, LLC
Shott Capital Management
Skyline Ventures
Sofinnova Ventures
Spencer Trask
SR One - GlaxoSmithKline
Sumitomo Corporation of America
SV Life Sciences
SVB Capital
TaiAn Technologies/Eminent VC
Takeda Research Investments, Inc.
Tang Capital Management, LLC
Tarplin, Downs and Young, LLC
Technology Partners
The Channel Group
The Pfizer Incubator, LLC
Thomas, McNerney & Partners
Toscana Ventures, Inc.
TPG Biotech
Trevi Health Ventures LP
TriState Ventures
US Venture Partners
USVP
VantagePoint Venture Partners
venBio
Venrock
Versant Ventures
VirtuaMed LLC
Vista Partners
Vivo Ventures
Warburg Pincus, LLC
WBB Securities LLC
Wedbush PacGrow Life Sciences
Westport Capital Markets, LLC
Wexford Capital LP
William Harris Investors
XShares Advisors
Yasuda Enterprise Development Co., Ltd.
Yasuda Enterprise Devlopment America
Yorkville Advisors
Zacks Investment Research